The improvement of biodegradable metals is currently an active and promising research area for their capabilities in implant manufacturing. However, controlling their degradation rate once their surface is in contact with the physiological media is a challenge. Surface treatments are in the way of addressing the improvement of this control. Zinc is a biocompatible metal present in the human body as well as a metal widely used in coatings to prevent corrosion, due to its well-known metal protective action. These two outstanding characteristics make zinc coating worthy of consideration to improve the degradation behaviour of implants. Electrodeposition is one of the most practical and common technologies to create protective zinc coatings on metals. This article aims to review the effect of the different parameters involved in the electrochemical process on the topography and corrosion characteristics of the zinc coating. However, certainly, it also provides an actual and comprehensive description of the state-of-the-art of the use of electrodeposited zinc for biomedical applications, focusing on their capacity to protect against bacterial colonization and to allow cell adhesion and proliferation.

Surface damage occurring during surgery can compromise coating integrity, leaving exposed areas susceptible to bacterial colonization. However, the impact of partial coating loss on antibacterial performance has not yet been investigated. In this work, a multifunctional UV-activated coating composed of hydroxyapatite, magnesium phosphate, and zinc oxide (HMZ) was developed and electrodeposited onto AZ31 and MgCa magnesium alloys. Its antibacterial efficacy against Staphylococcus aureus and Escherichia coli was evaluated under three conditions: adhered bacteria, planktonic cells, and biofilm. In the absence of UV activation, coated surfaces exhibited no significant antibacterial activity. In contrast, fully coated and UV-activated surfaces achieved bacterial reductions above 98% in all scenarios. Surfaces with 60% coverage showed antibacterial efficacy equivalent to that of fully coated surfaces, even against established biofilm. Surfaces with 30% coverage also exhibited moderate activity, particularly against adhered and planktonic bacteria. These results demonstrate that full surface coverage is not required to preserve the coating’s antibacterial effectiveness. This strategy provides a clinically relevant solution to maintain antibacterial protection even when coating integrity is compromised.